Kensington Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Kensington Investment Counsel's AMGN Position: Q1 2026 in Review
Kensington Investment Counsel reduced its Amgen (AMGN) stake by 2.5% in Q1 2026, selling an estimated $163K and leaving 17,615 shares worth $6.2M. The position accounts for 2.98% of the portfolio, ranked #8.
Kensington Investment Counsel first reported a position in AMGN in Q4 2020 and has held it in 21 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Kensington Investment Counsel held 17,615 shares of Amgen worth $6.2M as of Q1 2026.
- Kensington Investment Counsel sold 456 Amgen shares in Q1 2026, an estimated $163K.
- Amgen made up 2.98% of Kensington Investment Counsel's portfolio in Q1 2026, its #8 holding.
- Kensington Investment Counsel first reported a position in Amgen in Q4 2020 and has held it in 21 quarters since.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Kensington Investment Counsel's 13F filing for Q1 2026, filed 19 May 2026.